# PHASE 6 — STAGE 2
# Track 1A Closeout Record v1.0

**Status:** PASS / CLOSED
**Date:** 2026-08-15
**Scope:** Controlled Chat UI shell implementation

## 1. Objective

Implement the approved Track 1A Controlled Chat UI shell so that a real browser can open `/chat`, display the controlled interface, accept a user question, submit it through `POST /chat/query`, and display the returned response.

Track 1A was intentionally limited to the UI shell. It did not generalize PP selection and did not integrate the Chat UI with CER.

## 2. Implementation Scope

Implemented:

- `GET /chat`
- `POST /chat/query` UI-facing stub
- browser-rendered controlled Chat UI
- question input and Send control
- response/history display
- loading/error handling
- controlled-use disclaimer

The implementation was additive and did not redesign CER, retrieval, generation, validation, safety, or the existing `/cer/evaluate` path.

## 3. Changed Files

Track 1A implementation changed:

- `08_Development/implementation/src/safe_medical_ai/api/main.py`
- `08_Development/implementation/src/safe_medical_ai/api/chat_ui.py`
- `08_Development/implementation/tests/test_chat_ui.py`

## 4. Verification

Dedicated Track 1A verification:

- `13 passed`

Full implementation regression at Track 1A:

- `305 passed`

`git diff --check`:

- PASS

The implementation was independently validated against an isolated snapshot with the same passing result.

## 5. Human Run

Controlled browser Human Run:

1. `/chat` opened in a real browser — PASS
2. Chat UI rendered — PASS
3. Question input — PASS
4. Send action — PASS
5. `POST /chat/query` request — PASS
6. HTTP response — PASS
7. Placeholder response displayed — PASS

## 6. Boundary

Track 1A demonstrated only the browser/UI shell.

At Track 1A closeout:

- CER integration through Chat UI was not implemented.
- PP selection/navigation was not implemented.
- 239-PP execution was not implemented.
- No batch execution architecture was introduced.
- No clinical validation was claimed.
- No clinical deployment authorization was claimed.

## 7. Governance / Safety Boundary

The interface remained explicitly bounded to:

**Research / Development / Controlled Evaluation only.**

It was not represented as a clinical decision-making system, clinical guidance source, or clinically validated deployment.

This is consistent with the locked Phase 6 no-overclaim boundary.

## 8. Disposition

**TRACK 1A: PASS / CLOSED**

The approved Track 1A objective was adequately demonstrated.

No remediation loop is required.

No reopening of CER Run #001 or Webapp Controlled Trial #001 is required.

## 9. Explicit Non-Claims

Track 1A does **not** establish:

- real CER execution through Chat UI;
- multi-PP capability;
- 239/239 controlled-evaluation coverage;
- formal Phase 6 validation;
- clinical validation;
- clinical deployment authorization.

## 10. Handoff / Next State

Track 1A is closed.

Track 1B subsequently connected the already-proven Chat UI to the existing governed CER execution path. Track 2 remains the workstream required to advance controlled-evaluation coverage beyond the demonstrated PP-0002 boundary.

**Closeout principle:** once the approved Track 1A objective was demonstrated, no additional UI-shell refinement or QA loop was required merely for its own sake.
